Darilong 7.5 Tablet PR
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Darifenacin (7.5mg)
Overview Darilong 7.5 Tablet PR
Oxybutynin 7.5mg extended-release tablets are an anticholinergic medication employed to manage overactive bladder symptoms. This medication provides relief from urinary frequency, urgency, and incontinence. Always adhere to your physician's prescribed dosage and duration. It may be taken with or without food. Swallow the tablet whole; do not crush or chew. Discontinuing treatment prematurely may worsen symptoms; complete the prescribed course for optimal results. Common side effects include constipation, headache, dry mouth, urinary tract infections, nausea, and dry nose. Report any persistent or bothersome side effects to your doctor promptly; they can offer strategies for managing these effects. Before starting treatment, disclose all other medications and any existing health conditions. Inform your doctor if you are pregnant or breastfeeding. This medication is generally not suitable for patients with severe hepatic impairment; consult your physician before use.
Uses of Darilong 7.5 Tablet PR
Managing symptoms associated with overactive bladder
Major Benefits of Darilong 7.5 Tablet PR:
Follow your physician's instructions or consult the product information leaflet for usage guidelines. Darilong 7.5mg Tablets can be administered with or without food; however, consistent timing is recommended.
Common Side effects of Darilong 7.5 Tablet PR:
- Constipation
- Dryness in mouth
- Headache
- Dry eye
- Nasal dryness
How to use Darilong 7.5 Tablet PR:
Follow your doctor's instructions or the package insert for proper administration. Darilong 7.5 Tablet PR can be ingested with or without food; however, consistent daily timing is recommended.
How Darilong 7.5 Tablet PR works:
Darilong 7.5mg tablets (PR) are an antimuscarinic medication that eases urinary bladder muscle spasms, thereby reducing the frequency, urgency, and incontinence of urination.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Darilong 7.5 Tablet PR has an unknown safety profile. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Darilong 7.5 Tablet PR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Nursing mothers should likely avoid Darilong 7.5 Tablet PR. Available evidence indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Darilong 7.5 Tablet PR can induce adverse reactions that might impair driving skills. These reactions may include dizziness, blurry vision, insomnia, or somnolence, potentially affecting your ability to operate a vehicle.
KidneySAFE IF PRESCRIBED
Darilong 7.5 Tablet PR poses no known safety concerns for individuals with kidney impairment; dosage modification is unnecessary. Nevertheless, disclosure of pre-existing kidney conditions to your physician is advisable.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Darilong 7.5 Tablet PR. Dosage modification of Darilong 7.5 Tablet PR may be necessary. Physician consultation is advised.
What if you forget to take Darilong 7.5 Tablet PR :
Should you forget a Darilong 7.5 Tablet PR dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Darilong 7.5 Tablet PR
| Label | Value |
|---|---|
| Chemical Type | Diphenylmethane-based compound |
| Developing Habits | No. |
| Treatment Category | Urologic Care |
3,018 People bought this recently